|
|
40
|
|
|
B001D
|
|
|
CABERGOLINE 0.5MG TAB (TMP/AHI)
|
|
|
CABERGOLINE
|
|
|
CABERGOLINE
|
|
|
4'S
|
|
|
BQ
|
|
|
30.83
|
|
|
7.71
|
|
|
0.5MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
TMP
|
|
|
THE MADRAS PHARMACEUTICALS
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
283620
|
|
|
DOPAMINE RECEPTOR AGONIST
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|